Koshinski Asset Management, Inc. Natera, Inc. Transaction History

Koshinski Asset Management, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 12, 2022	SELL	$28.13 - $44.54 $956 - $1,514	-34 Closed	0 $0
Q3 2021 Oct 12, 2021	BUY	$100.17 - $126.36 $3,405 - $4,296	34 New	34 $3,000
Q1 2021 May 06, 2021	SELL	$91.47 - $124.36 $347,768 - $472,816	-3,802 Closed	0 $0
Q4 2020 Mar 30, 2021	BUY	$66.66 - $111.74 $116,854 - $195,880	1,753 Added 85.55%	3,802 $378,000
Q4 2020 Feb 05, 2021	BUY	$66.66 - $111.74 $136,586 - $228,955	2,049 New	2,049 $378,000

528

119M

308K

191K

Ticker NTRA
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 96,957,400
Market Cap $16.3B
Description
Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify sing...

Get notified when there are updates to the investment portfolio of Koshinski Asset Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Koshinski Asset Management, Inc. with notifications on news.